Skip to main content
1-877-936-8422
VICC
Search
Main navigation
Home
Patient Care
Cancer Care Overview
Find a Doctor
Request an Appointment
Find a Clinical Trial
MyHealth at Vanderbilt
Support & Education
Cancer Information
Clinical Trials
Clinical Trials Overview
Frequently Asked Questions
Trial Search for Physicians
Trial Search For Patients
Flowcharts
Research
Research Overview
Research Programs
Shared Resources
Clinical Trials
Member Directory
Membership Information
Funding Opportunities
Giving
Giving & Impact
Make a Gift
Donor-Supported Research
Volunteer
Community
Community Overview
Advocacy
VICC Ambassadors
Education
Education, Training, and Career Development
Annual Scientific Retreat
About
About Vanderbilt-Ingram
Leadership
Fast Facts
History
Careers
For Media
More
Intranet (for faculty and staff)
About the site
Help
Contact the web team
Prices
Search
at Vanderbilt-Ingram Cancer Center
Site Search
All
Pages
Members
Clinical Trials
News
1120 results found
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Relevance:
1
Testing Chemotherapy versus Chemotherapy plus Radiotherapy Prior to Limited Surgery for Early Rectal Cancer
Relevance:
1
Dinutuximab with Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children with Newly Diagnosed High Risk Neuroblastoma
Relevance:
1
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Relevance:
1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors
Relevance:
1
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Relevance:
1
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Relevance:
1
A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS, CMML, or AML
Relevance:
1
A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumor
Relevance:
1
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2 Related Genetic Alterations (MK-6482-015)
Relevance:
1
Pagination
Previous page
‹ previous
…
Page
42
Page
43
Page
44
Page
45
Current page
46
Page
47
Page
48
Page
49
Page
50
…
Next page
next ›